Neuronetics, Inc. (STIM) intrinsic value & 10-year financials
Neuronetics, Inc. (STIM) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 17.8% a year to $149.2M, with an average return on invested capital of -282.4%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.88
- Market cap
- $124.3M
- Revenue (FY2025)
- $149.2M
- Revenue growth (10-yr CAGR)
- 17.8%
- ROIC (10-yr avg)
- -282.4%
- Free cash flow (FY2025)
- -$21.2M
STIM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $149.2M | -$39.0M | -$0.59 | -$21.2M | -21.1% | -47.0% |
| FY2024 | $74.9M | -$43.7M | -$0.69 | -$32.5M | -46.2% | -70.9% |
| FY2023 | $71.3M | -$30.2M | -$0.53 | -$34.4M | -42.8% | -97.7% |
| FY2022 | $65.2M | -$37.2M | -$0.69 | -$34.0M | -53.8% | -133.8% |
| FY2021 | $55.3M | -$31.2M | -$0.61 | -$30.3M | -49.8% | -141.2% |
| FY2020 | $49.2M | -$27.5M | -$0.73 | -$29.1M | -45.3% | -272.0% |
| FY2019 | $62.7M | -$29.0M | -$0.79 | -$31.3M | -43.0% | -2100.8% |
| FY2018 | $52.8M | -$24.1M | — | -$21.6M | -37.6% | 24.7% |
| FY2017 | $40.4M | -$16.1M | — | -$11.7M | -33.7% | 8.4% |
| FY2016 | $34.2M | -$11.2M | — | -$8.9M | -27.3% | 6.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Neuronetics, Inc. is a consistent compounder, expanding top-line revenue at 17.8% annually over the past decade.
Neuronetics, Inc. has historically struggled to out-earn its cost of capital, averaging just -47.5% ROIC.
Neuronetics, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Neuronetics, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-19.60 per share.